See All Slides - tctmd.com

Slides

Presentation

Meta-analysis of Randomized Controlled Trials on the Risk of Bleeding with Dabigatran

Presenter: B.J. Bloom

January 06, 2014

Presentation

Comparison of Cost-Effectiveness of Oral Rapamycin Plus BMS vs. First-Generation DES

Presenter: Alfredo E. Rodriguez

December 30, 2013

Presentation

Comparative Effectiveness of Endovascular vs. Open Repair of Ruptured AAA in the Medicare Population

Presenter: S.T. Edwards

December 29, 2013

Presentation

Changes in Geographic Variation in Use of PCI for Stable Ischemic Heart Disease after COURAGE

Presenter: Arun V. Mohan

December 26, 2013

Presentation

Comparison of Intermediate Term Outcomes for CABG vs. DES for Patients ≥ 75 Years of Age

Presenter: Edward L. Hannan

December 25, 2013

Presentation

Efficacy and Safety of Dabigatran vs. Warfarin in Relation to Baseline Renal Function in A-fib Patients

Presenter: Ziad Hijazi

December 23, 2013

Presentation

A Phase 2 Placebo-Controlled Trial Demonstrating Reversal of Rivaroxaban-induced Anticoagulation

Presenter: Mark Crowther

December 22, 2013

Presentation

Alberta Stroke Program Early CT Score to Select Patients for Endovascular Treatment in IMS-III

Presenter: Michael D. Hill

December 19, 2013

Presentation

Comparison of Newer-Generation DES with BMS in Patients with Acute STEMI

Presenter: M. Sabat?

December 19, 2013

Presentation

RE-COVER 2: Treatment of Acute VTE with Dabigatran or Warfarin and Pooled Analysis

Presenter: Sam Schulman

December 18, 2013

Advertisement

Slides

Meta-analysis of Randomized Controlled Trials on the Risk of Bleeding with Dabigatran

Comparison of Cost-Effectiveness of Oral Rapamycin Plus BMS vs. First-Generation DES

Comparative Effectiveness of Endovascular vs. Open Repair of Ruptured AAA in the Medicare Population

Changes in Geographic Variation in Use of PCI for Stable Ischemic Heart Disease after COURAGE

Comparison of Intermediate Term Outcomes for CABG vs. DES for Patients ≥ 75 Years of Age

Efficacy and Safety of Dabigatran vs. Warfarin in Relation to Baseline Renal Function in A-fib Patients

A Phase 2 Placebo-Controlled Trial Demonstrating Reversal of Rivaroxaban-induced Anticoagulation

Alberta Stroke Program Early CT Score to Select Patients for Endovascular Treatment in IMS-III

Comparison of Newer-Generation DES with BMS in Patients with Acute STEMI

RE-COVER 2: Treatment of Acute VTE with Dabigatran or Warfarin and Pooled Analysis

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content